Tamoxifen combined with coenzyme Q10 for idiopathic oligoasthenospermia.
- Author:
Kai-Fa TANG
1
;
Yao XING
;
Chun-Yun WU
;
Rui-Zhe LIU
;
Xin-Yang WANG
;
Jun-Ping XING
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Humans; Male; Oligospermia; drug therapy; Tamoxifen; therapeutic use; Treatment Outcome; Ubiquinone; analogs & derivatives; therapeutic use; Young Adult
- From: National Journal of Andrology 2011;17(7):615-618
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the effects of tamoxifen (TMX) combined with coenzyme Q10 (CoQ10) on idiopathic oligoasthenospermia.
METHODSA total of 183 patients with idiopathic oligoasthenospermia were randomly divided into a TMX + CoQ10 group (n = 63), a TMX group (n = 61) and a CoQ10 group (n = 59). At the end of 3 and 6 months of treatment, semen analyses and hormone tests were performed, and the results were compared with those obtained before the treatment.
RESULTSCompared with the pre-treatment results, the levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH) and testosterone (T) and sperm concentration were significantly elevated in the TMX + CoQ10 and TMX groups (P < 0.05), but showed no significant difference in the CoQ10 group (P > 0.05); sperm motility and morphologically normal sperm were increased significantly in the TMX + CoQ10 and CoQ10 groups (P < 0.05), and slightly in the TMX group but with no statistically significant difference (P > 0.05).
CONCLUSIONTamoxifen combined with CoQ10 can significantly improve sperm concentration, motility and morphology in patients with idiopathic oligoasthenospermia.
